Loading song details...
AGDD 2024 D2S14 Closing Remarks
No description available.
MP3 Download
Video Download
Related Songs
7:07
AGDD 2024 D2S14 Closing Remarks
17:49
GDF 2024 D2S14 Improving The Sterility Assurance Application To FDA
17:12
AGDD 2024 D1S07 Enhanced Understanding Of Structure Performance Relationship Using Modeling
29:19
AGDD 2024 D2S07 The Journey Of First Approvals Complex Generic Long Acting Injectable Products
22:47
AGDD 2024 D1S14 Drug Device Combination Products A New Methodology For Evaluation
11:56
AGDD 2024 D2S10 2 Analysis Of ANDA Approval And Major Deficiencies A Case Study With Topical
21:06
AGDD 2024 D2S09 Guidance For Industry Content And Format Of Composition Statement
23:15
AGDD 2024 D2S03 Quality Consideration For First Generic Tiotropium Bromide Capsule Based
12:28
AGDD 2024 D1S15 Approaches To Analyzing Comparative Use Human Factors Studies
21:59
AGDD 2024 D2S02 Quality Considerations For First Generic Oral Liquids
9:20
AGDD 2024 D2S10 1 Analysis Of First Cycle BE Adequacy And Major Deficiencies Encountered
15:29
AGDD 2024 D1S11 Orally Inhaled Drug Product PSGs Considerations For Using Modeling And Sim
22:07
AGDD 2024 D2S06 Emerging Generic Oligonucleotides Challenges And Progress
22:53
AGDD 2024 D1S10 Orally Inhaled Drug Product PSGs General Considerations Using The Alternative
27:38
AGDD 2024 D2S04 Q A Discussion Panel 1
5:24
AGDD 2024 D1S16 Closing Remarks From Day One
17:29
AGDD 2024 D1S01 Keynote Address
15:57
AGDD 2024 D1S04 Application Of Adaptive Perfusion As In Vitro Release Testing Method
22:02
AGDD 2024 D2S11 ICH M13A First Guideline For Bioequivalence
18:42